We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Discovery Labs Submits Response to Second FDA Approvable Letter
Discovery Labs Submits Response to Second FDA Approvable Letter
December 5, 2007
Discovery Labs is continuing to pursue approval for its respiratory distress syndrome treatment Surfaxin during the first half of 2008 and has submitted its response to a second FDA approvable letter.